Treatment advances in small cell lung cancer (SCLC)

Zelen M, Keynote address on biostatistics and data retrieval. Cancer chemotherapy reports. ,vol. 4, pp. 31- 42 ,(1973)

Mark G. Kris, Richard J. Gralla, Chemotherapy in non-small cell lung cancer: results of recent trials. Seminars in Oncology. ,vol. 15, pp. 2- 5 ,(1988)

Janet L. DeMayo, Stephen B. Baylin, Douglas W. Ball, R. Ilona Linnoila, Bihong Zhao, Franco J. DeMayo, Barry D. Nelkin, Constitutive Achaete-Scute Homologue-1 Promotes Airway Dysplasia and Lung Neuroendocrine Tumors in Transgenic Mice Cancer Research. ,vol. 60, pp. 4005- 4009 ,(2000)

Laura R. Saunders, Alexander J. Bankovich, Wade C. Anderson, Monette A. Aujay, Sheila Bheddah, KristenAnn Black, Radhika Desai, Paul A. Escarpe, Johannes Hampl, Amy Laysang, David Liu, Javier Lopez-Molina, Milly Milton, Albert Park, Marybeth A. Pysz, Hui Shao, Brian Slingerland, Michael Torgov, Samuel A. Williams, Orit Foord, Philip Howard, Jacek Jassem, Andrzej Badzio, Piotr Czapiewski, David H. Harpole, Afshin Dowlati, Pierre P. Massion, William D. Travis, M. Catherine Pietanza, J. T. Poirier, Charles M. Rudin, Robert A. Stull, Scott J. Dylla, A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo Science Translational Medicine. ,vol. 7, ,(2015) , 10.1126/SCITRANSLMED.AAC9459

W K Evans, F A Shepherd, R Feld, D Osoba, P Dang, G Deboer, VP-16 and cisplatin as first-line therapy for small-cell lung cancer. Journal of Clinical Oncology. ,vol. 3, pp. 1471- 1477 ,(1985) , 10.1200/JCO.1985.3.11.1471

N Murray, P Coy, J L Pater, I Hodson, A Arnold, B C Zee, D Payne, E C Kostashuk, W K Evans, P Dixon, Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology. ,vol. 11, pp. 336- 344 ,(1993) , 10.1200/JCO.1993.11.2.336

A Gregor, P Drings, J Burghouts, P E Postmus, D Morgan, T Sahmoud, A Kirkpatrick, O Dalesio, G Giaccone, Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study. Journal of Clinical Oncology. ,vol. 15, pp. 2840- 2849 ,(1997) , 10.1200/JCO.1997.15.8.2840

Dimosthenis V Skarlos, E Samantas, P Kosmidis, George Fountzilas, M Angelidou, Ph Palamidas, N Mylonakis, A Provata, E Papadakis, G Klouvas, D Theocharis, E Panousaki, E Boleti, G Sphakianoudis, Nicholas Pavlidis, Lung Cancer Study Group, Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer A Hellenic Co-operative Oncology Group study Annals of Oncology. ,vol. 5, pp. 601- 607 ,(1994) , 10.1093/OXFORDJOURNALS.ANNONC.A058931

P Warde, D Payne, Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. Journal of Clinical Oncology. ,vol. 10, pp. 890- 895 ,(1992) , 10.1200/JCO.1992.10.6.890

A Ardizzoni, H Hansen, P Dombernowsky, T Gamucci, S Kaplan, P Postmus, G Giaccone, B Schaefer, J Wanders, J Verweij, Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group. Journal of Clinical Oncology. ,vol. 15, pp. 2090- 2096 ,(1997) , 10.1200/JCO.1997.15.5.2090